Cigna Investments’s XPeng XPEV Stock Holding History

Cigna Investments’s Portfolio XPEV Stock Details XPEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,300	Closed	-$263K	–	457
2022 Q2	$263K	Buy	8,300 +561	+7%	+$14.4K	0.05%	368
2022 Q1	$214K	Buy	7,739 +1,003	+15%	+$35.6K	0.03%	548
2021 Q4	$339K	Hold	6,736	–	–	0.03%	472
2021 Q3	$239K	Buy	6,736 +891	+15%	+$35.4K	0.02%	645
2021 Q2	$260K	Buy	+5,845	New	+$199K	0.02%	628

Other funds holding XPEV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

PCM

Primavera Capital Management George Town, Cayman Islands $648M AUM 6.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

Cigna Investments's XPEV Position: Q3 2022 in Review

Cigna Investments sold out of XPeng (XPEV) in Q3 2022, closing a stake of 8,300 shares — an estimated $263K sold.

Cigna Investments first reported a position in XPEV in Q2 2021 and held it in 5 quarters. The position peaked at $339K in Q4 2021. 263 funds tracked by Wall St. Rank hold XPEV as of Q3 2022.

Cigna Investments reported no remaining XPeng position as of Q3 2022 after selling out during the quarter.
Cigna Investments sold 8,300 XPeng shares in Q3 2022, an estimated $263K.
Cigna Investments first reported a position in XPeng in Q2 2021 and held it in 5 quarters.
Cigna Investments's XPeng position peaked at $339K in Q4 2021.
263 funds tracked by Wall St. Rank held XPeng as of Q3 2022.

Based on Cigna Investments's 13F filing for Q3 2022, filed 14 Nov 2022.